- Home
- CLIR vs FGEN Comparison
CLIR vs FGEN Comparison
Compare CLIR & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIR
- FGEN
- Stock Information
- Founded
- CLIR 2008
- FGEN 1993
- Country
- CLIR United States
- FGEN United States
- Employees
- CLIR N/A
- FGEN N/A
- Industry
- CLIR Industrial Machinery/Components
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- CLIR Industrials
- FGEN Health Care
- Exchange
- CLIR Nasdaq
- FGEN Nasdaq
- Market Cap
- CLIR 30.9M
- FGEN 33.5M
- IPO Year
- CLIR 2012
- FGEN 2014
- Fundamental
- Price
- CLIR $0.69
- FGEN $0.29
- Analyst Decision
- CLIR Strong Buy
- FGEN Strong Buy
- Analyst Count
- CLIR 1
- FGEN 1
- Target Price
- CLIR $2.00
- FGEN $10.00
- AVG Volume (30 Days)
- CLIR 63.7K
- FGEN 760.5K
- Earning Date
- CLIR 05-21-2025
- FGEN 05-12-2025
- Dividend Yield
- CLIR N/A
- FGEN N/A
- EPS Growth
- CLIR N/A
- FGEN N/A
- EPS
- CLIR N/A
- FGEN N/A
- Revenue
- CLIR $2,895,000.00
- FGEN $6,996,000.00
- Revenue This Year
- CLIR $32.84
- FGEN $232.81
- Revenue Next Year
- CLIR $107.68
- FGEN $9.16
- P/E Ratio
- CLIR N/A
- FGEN N/A
- Revenue Growth
- CLIR 10.88
- FGEN N/A
- 52 Week Low
- CLIR $0.46
- FGEN $0.18
- 52 Week High
- CLIR $1.72
- FGEN $1.53
- Technical
- Relative Strength Index (RSI)
- CLIR 57.09
- FGEN 41.96
- Support Level
- CLIR $0.56
- FGEN $0.29
- Resistance Level
- CLIR $0.71
- FGEN $0.34
- Average True Range (ATR)
- CLIR 0.09
- FGEN 0.02
- MACD
- CLIR 0.01
- FGEN -0.00
- Stochastic Oscillator
- CLIR 62.86
- FGEN 18.16
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.